• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

Workshop on “Knowledge on Artificial Intelligence applied to treatments decision-making”

As a member of the Horizon I3Lung project, Lung Cancer Europe (LuCE) will hold a workshop to explore the knowledge and trust on Artificial Intelligence (AI) of people impacted by lung cancer across Europe. Deadline to apply is June 15th, 2023.

8th LuCE Report – SURVEY: Financial impact of lung cancer. A European perspective.

8th LuCE Report – SURVEY: Financial impact of lung cancer. A European perspective: We are collecting data through an online survey, which objective is to explore the financial repercussions and difficulties experienced by people impacted by lung cancer in Europe.

A warm welcome to LuCE’s New Board

We wish to announce the newly elected LuCE Executive Board elected at the Annual General Meeting on 13 May 2023.

ERS International Congress 2023: Registration for patient representatives is now open.

The European Respiratory Society (ERS) International Congress 2023 will take place from 9–13 September 2023. It will be a hybrid conference, with the option to participate online or in person in Milan, Italy. Registration for representatives of patient organisations is now open.

EPF Artificial Intelligence Survey

EPF began engaging in Artificial Intelligence (AI) in healthcare in 2020, from both a policy and capacity- building perspective.

Highlights of ELCC 2023

Lung Cancer Europe – Highlights of #ELCC2023